Table 2.
Histopathologic Studies
Group | Description | n | Hepatocyte size units (mean ± S.D.) |
pa | No. of labeled hepatocytes per 100 hepatocytesb (mean ± S.D.) |
pa | ||
---|---|---|---|---|---|---|---|---|
Before | 2 weeks | Sacrifice | Sacrifice | |||||
1 | PCS | 6 | 0.365 ± 0.048 | 0.141 ± 0.020 | — | 13.8 ± 1.6 | — | |
2 | PCS + BF | 10 | 0.358 ± 0.070 | 0.158 ± 0.020 | NSc | 13.9 ± 1.2 | NS | |
3 | PCS | 10 | 0.354 ± 0.031 | 0.154 ± 0.036 | — | 14.3 ± 1.8 | — | |
4 | PCS + BF (staged) | 5 | 0.356 ± 0.063 | 0.159d ± 0.025 | 0.158 ± 0.009 | NS | 15.1 ± 2.9 | NS |
5 | IB | 5 | 0.351 ± 0.034 | 0.328 ± 0.035 | <0.01 | 1.64 ± 0.3 | <0.001 | |
6 | PCS + IB | 10 | 0.354 ± 0.048 | 0.138 ± 0.011 | NS | 13.8 ± 2 | NS | |
7 | PCS + IB (staged) | 10 | 0.358 ± 0.054 | 0.173d ± 0.036 | 0.162 ± 0.030 | NS | 16.1 ± 1.6 | NS |
Statistical comparisons were between Group 2 vs. Group 1 (control) and Groups 4 to 7 at sacrifice vs. Group 3 (control).
In normal unoperated dogs, the labeling is 1.6 ± 0.4 (7).
NS, not significant.
The atrophy at 2 weeks was explained by the PCS which was the first stage operation.